Clinical trial
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
NCT00019006 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019006 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer |
| Official title | Phase I Pilot Study of Vaccine Therapy With Tumor-Specific Mutated Ras Peptides in the Adjuvant Setting in Patients With Colorectal, Pancreatic, or Lung Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer, Stage III Pancreatic Cancer, Stage III Rectal Cancer, Limited Stage Small Cell Lung Cancer, Recurrent Pancreatic Cancer, Recurrent Rectal Cancer, Stage III Non-small Cell Lung Cancer, Stage I Pancreatic Cancer, Stage II Non-small Cell Lung Cancer and 4 more |
| Intervention type | Drug |
| Interventions | Detox-B adjuvant, ras peptide cancer vaccine |
| Start date | Mar 1, 1995 |
| First posted | Mar 2, 2007 |
| Last update posted | Mar 4, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: